Association of HLA-A*3303-B*4403-DRB1*1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population.
Herpes zoster is a common disease caused by reactivation of the varicella zoster virus (VZV). In a small number of herpes zoster patients, pain persists beyond 4 weeks or more after healing of vesicular eruptions; this condition is termed postherpetic neuralgia (PHN). Positive associations of human histocompatibility leukocyte antigens (HLA) class I antigens, A33 and B44, with PHN in the Japanese population have been reported. Our hypothesis is that susceptibility genes to PHN might exist in the HLA region and the study objective is to further examine possible associations of genes in HLA class I, II and III regions, HLA-A, -B, -DRB1, tumor necrosis factor alpha (TNFA) promoter, and a natural killer cell activating receptor, NKp30 polymorphisms with PHN. Although TNFA or NKp30 in the class III region had been considered as a candidate locus, we found no associations of TNFA promoter or NKp30 polymorphisms with PHN in this study. We demonstrated that HLA-A*3303, -B*4403 and -DRB1*1302 alleles were significantly associated with PHN (P = 0.0007 for A*3303, P = 0.001 for B*4403 and P = 0.001 for DRB1*1302). The frequency of the HLA-A*3303-B*4403-DRB1*1302 haplotype was also significantly higher in the PHN patients than in the healthy controls (P = 0.0039). Our results suggest that this haplotype might be related to the pathogenesis of PHN.
Sato
M
M
Department of Research, Tokyo Metropolitan Red Cross Blood Center, Tokyo, 150-0012 Japan.
Ohashi
J
J
Tsuchiya
N
N
Kashiwase
K
K
Ishikawa
Y
Y
Arita
H
H
Hanaoka
K
K
Tokunaga
K
K
Yabe
T
T
D000328:Adult; D000368:Aged; D005260:Female; D008040:Genetic Linkage / Q000235:genetics; D015234:HLA-A Antigens / Q000235:genetics*; D015235:HLA-B Antigens / Q000235:genetics*; D059948:HLA-B44 Antigen; D006684:HLA-DR Antigens / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006239:Haplotypes / Q000235:genetics; D006562:Herpes Zoster / Q000235:genetics*; D006801:Humans; D007564:Japan; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism; D008297:Male; D055628:Natural Cytotoxicity Triggering Receptor 3; D009437:Neuralgia / Q000235:genetics* / Q000276:immunology* / Q000821:virology; D011110:Polymorphism, Genetic / Q000276:immunology; D011401:Promoter Regions, Genetic; D011971:Receptors, Immunologic / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D015234:HLA-A Antigens; C082945:HLA-A*33 antigen; D015235:HLA-B Antigens; D059948:HLA-B44 Antigen; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; C431710:NCR3 protein, human; D055628:Natural Cytotoxicity Triggering Receptor 3; D011971:Receptors, Immunologic; D014409:Tumor Necrosis Factor-alpha